Leveraging genetic data to improve the care of patients with thoracic aortic dilation
Polygenic score for ascending thoracic aortic diameter Thoracic event predictionScreening for thoracic aortic dilation Leveraging genetic data to improve thoracic aortic dilation management Potential future implementation of the AORTA Gene model to improve the treatment of individuals with thoracic aortic disease.The AORTA Gene model is derived from the integration of a polygenic score for ascending aortic diameter into the clinical AORTA Score.AORTA Gene can potentially be applied to determine patients who warrant screening for thoracic aortic dilation.In the future it is hoped that similar models will be able to be inform who may benefit from aggressive medical management or earlier elective surgical intervention based on individual-level risk.This figure was generated with Biorender.com
Authors
- John DePaolo (ORCID: https://orcid.org/0000-0002-6829-2594)
- Scott M. Damrauer (ORCID: https://orcid.org/0000-0001-8009-1632)
- David Zhang (ORCID: https://orcid.org/0000-0003-1377-9829)
Institutions
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1093/eurheartj/ehae499
- Citations
- 3
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- American Heart Association